A comparative study of the dorsolateral prefrontal cortex targeting approaches for transcranial magnetic stimulation treatment: Insights from the healthy control data

• Published in: Brain research Vol. 1838; p. 148989
• Main Authors: Kinjo, Megumi, Honda, Shiori, Wada, Masataka, Nakajima, Shinichiro, Koike, Shinsuke, Noda, Yoshihiro
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2024
• Subjects: Beam F3 method; Depression; Dorsolateral prefrontal cortex (DLPFC); Neurology; Personalized targeting approach; Resting-state functional magnetic resonance imaging (rs-fMRI); Transcranial magnetic stimulation (TMS); Transcranial magnetic stimulation (TMS); Depression; Dorsolateral prefrontal cortex (DLPFC); Personalized targeting approach; Beam F3 method; Resting-state functional magnetic resonance imaging (rs-fMRI)
• ISSN: 0006-8993; 1872-6240; 1872-6240
• DOI: 10.1016/j.brainres.2024.148989

[Display omitted] •rs-fMRI targeting yielded higher inter-subject variability when using HC data.•Targets by conventional approaches were distanced from the average rs-fMRI target.•Conventional targeting approaches had weak functional connectivity with SGC.•Conventional targeting approaches yielded variable functional connectivity with SGC. Repetitive transcranial magnetic stimulation (rTMS) to the left dorsolateral prefrontal cortex (DLPFC) is an established treatment for medication-resistant depression. Several targeting methods for the left DLPFC have been proposed including identification with resting-state functional magnetic resonance imaging (rs-fMRI) neuronavigation, stimulus coordinates based on structural MRI, or electroencephalography (EEG) F3 site by Beam F3 method. To date, neuroanatomical and neurofunctional differences among those approaches have not been investigated on healthy subjects, which are structurally and functionally unaffected by psychiatric disorders. This study aimed to compare the mean location, its dispersion, and its functional connectivity with the subgenual cingulate cortex (SGC), which is known to be associated with the therapeutic outcome in depression, of various approaches to target the DLPFC in healthy subjects. Fifty-seven healthy subjects underwent MRI scans to identify the stimulation site based on their resting-state functional connectivity and were measured their head size for targeting with Beam F3 method. In addition, we included two fixed stimulus coordinates over the DLPFC in the analysis, as recommended in previous studies. From the results, the rs-fMRI method had, as expected, more dispersed target sites across subjects and the greatest anticorrelation with the SGC, reflecting the known fact that personalized neuronavigation yields the greatest antidepressant effect. In contrast, the targets located by the other methods were relatively close together with less dispersion, and did not differ in anticorrelation with the SGC, implying their limitation of the therapeutic efficacy and possible interchangeability of them.